{"organizations": ["Morgan Stanley Global Healthcare Conference", "Intellicure, Inc.", "Gilead", "Association", "AMA House of Delegates IPC The Hospitalist Company, Inc", "NYSM", "EHR-based Collaborative Solutions for Wound Care", "GLU", "Pfizer Settle Lipitor Litigation Worldwide Monogram Biosciences Collaborates", "Ranbaxy", "Neurocrine Biosciences", "The American Medical", "Neurocrine", "Butterfly Effects Completes Acquisition of Autism Treatment Solutions", "Gilead Sciences", "Hospitalist Company, Inc.", "Neurocrine ... Healthcare Conference", "Global Dementia Partnering", "Autism Treatment Solutions"], "uuid": "43cfd559c978685f14caa92472becceb033e7214", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Dermatological-Drugs-Market-Forecast-2015-2025-3A-Opportunities-for-Leading-Companies-48244-1/", "country": "US", "title": "Dermatological Drugs Market Forecast 2015-2025: Opportunities for Leading Companies", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Dermatological Drugs Market Forecast 2015-2025: Opportunities for Leading Companies", "spam_score": 0.0, "site_type": "news", "published": "2015-09-10T15:19:00.000+03:00", "replies_count": 0, "uuid": "43cfd559c978685f14caa92472becceb033e7214"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Dermatological-Drugs-Market-Forecast-2015-2025-3A-Opportunities-for-Leading-Companies-48244-1/", "ord_in_thread": 0, "title": "Dermatological Drugs Market Forecast 2015-2025: Opportunities for Leading Companies", "locations": ["California", "Ore", "New York City", "Calif.", "US", "New York", "U.S.", "Boston", "CORVALLIS", "SAN DIEGO", "GURGAON"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Gurman", "Andrew W. Gurman", "Kevin Gorman", "Jojoba Oil", "Stockton", "Virgin"], "text": "  The Dementia ... the dementia partnering deals and agreements entered into ... in dementia partnering deals Top dementia deals by ... stage of development, technology type The Dementia ... dementia partnering deals and agreements entered into by ... (Date:9/10/2015)... SAN DIEGO , Sept. 10, 2015 Neurocrine ... Kevin Gorman , resident and CEO of Neurocrine ... Healthcare Conference in New York City ... Thursday, September 17 at 8:00am ET (5:00am PT). The ... the Company,s website at http://www.neurocrine.com . ... (Date:9/10/2015)... Sept. 10, 2015 Orthology, an innovative, cost-effective ... injuries, chronic pain, and orthopedic surgeries, as well ... (NYSM), New York,s leading ... company. NYSM currently operates three NYC locations at ... Based on a patent-pending, research-based methodology developed ... [ 0 ] Global Dementia Partnering 2010-2015 [ 0 ] Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference [ 0 ] Orthology Acquires NYSportsMed In New York City  9/11/2015)... ... September 11, 2015 , ... ... has completed the acquisition of Autism Treatment Solutions, LLC of Stockton, California (“ATS” ... a significant presence in northern California and bolsters Butterfly Effects national footprint. , ... (Date:9/10/2015)... ... September 10, 2015 , ... Intellicure, Inc. ... remains focused on assisting new and existing customers to achieve operational efficiencies and ... organization remain appropriately resourced, and as such has created a new position   ... on September   ... support. The program   ... (Date:9/10/2015)... ... ... if one product could replace an entire bathroom cabinet full of failed health and ... Jojoba Oil is the one skin care treatment that will satisfy and succeed where ... Naturals’ Jojoba Oil are well-documented:, 100% Natural: Pure, Virgin, ... (Date:9/10/2015)... ... September 10, 2015 , ... PetPace, the provider of an ... and activity, today released the findings of a new medical case study. The ... for download here , documents in detail how the PetPace collar detected multiple ... [ 0 ] Butterfly Effects Completes Acquisition of Autism Treatment Solutions, LLC [ 0 ] Intellicure, Inc., the Leader in EHR-based Collaborative Solutions for Wound Care and Hyperbaric Medicine, Appoints New Solutions Development Specialist   Simplify Your Anti-Aging Regimen - Jojoba Oil: One Product, Many Uses [ 1 ] A New Case Study Reveals that the Petpace Smart Collar Provides Real-Time Indication of Gastro-Intestinal Distress ... CORVALLIS, Ore. Some migratory songbirds figure out the ... of others that successfully have had baby birds ... playing recorded songs induced them to nest in places ... songbirds have more complex communication abilities than had previously ... ... Will Market Generic Atorvastatin in the U.S. With 180 Days ... ... Also Resolves Caduet, Accupril Litigation in the US, GURGAON, ... (Ranbaxy), announced today that it has entered,into an agreement with ... ... and PhenoSense Integrase(TM) assays used to study ... promising new Integrase inhibitor, ... MGRM ) announced today that the Company has,signed an ... services for Gilead,s Elvitegravir Phase III,studies. Monogram assays will be ... ... June 18 Cytopia Limited (ASX:,CYT) will present details ... Protein Kinase Targets conference, a leading conference for,breakthrough scientific ... held from 23 to 25 June in Boston, USA., ... from the Cytopia FMS,program and will be presented by ... ... 17 The American Medical,Association (AMA) announced today ... orthopaedic hand surgeon, to his second consecutive,term as ... In this position, Dr.,Gurman will assist in presiding ... organization., \"I look forward to continuing to ... ... Calif., June 17 IPC The,Hospitalist Company, Inc. (Nasdaq: ... today announced that it continues to experience,favorable trends in ... be in the range of $57 million to $59 ... $4.2 million to $4.6 million. Absent the,impact of acquisitions, ... Birds communicate reproductive success in song Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies Cytopia To Present Data on FMS Program With Anticancer Potential Andrew W. Gurman, M.D., Re-Elected to Vice Speaker, AMA House of Delegates IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook CRP Liquid Conrtols level 3... The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid.... Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma.... For the quantitative in vitro determination of Ammonia in plasma...", "external_links": [], "published": "2015-09-10T15:19:00.000+03:00", "crawled": "2015-09-11T13:24:16.231+03:00", "highlightTitle": ""}